Preface ......................................................... v
Contributors ................................................... ix
1 The Methodology of Neuroproteomics ........................... 1
Andrew K. Ottens
Part I Disease Models in Neuroproteomics
2 Modeling Cerebral Ischemia in Neuroproteomics ............... 25
Jitendra R. Dave, Anthony J. Williams, Changping Yao,
X.-C. May Lu, and Frank С. Tortella
3 Clinical and Model Research of Neurotrauma .................. 41
András Büki, Erzsébet Kövesdi, József Pál, and Endre
Czeiter
4 Neuroproteomic Methods in Spinal Cord Injury ................ 57
Anshu Chen and Joe E. Springer
5 Modeling Substance Abuse for Applications in Proteomics ..... 69
Scott E. Hemby and Nilesh Tannu
6 Protein Aggregate Characterization in Models of
Neurodegenerative Disease ................................... 85
Andrew T.N. Tebbenkamp and David R. Borchelt
Part II Sub-Proteome Separations and Neuroproteomic Analysis
7 Sub-Proteome Processing: Isolation of Neuromelanin
Granules from the Human Brain ............................... 95
Florian Tribl
8 Proteomic Analysis of Protein Phosphorylation and
Ubiquitination in Alzheimer's Disease ...................... 109
Stefani N. Thomas, Diane Cripps, and Austin J. Yang
9 Proteomics Identification of Carbonylated and HNE-Bound
Brain Proteins in Alzheimer's Disease ...................... 123
Rukhsana Sultana and D. Allan Butterfield
10 Mass Spectrometric Identification of In Vivo
Nitrotyrosine Sites in the Human Pituitary Tumor
Proteome ................................................... 137
Xianquan Zhan and Dominic M. Desiderio
11 Improved Enrichment and Proteomic Analysis of Brain
Proteins with Signaling Function by Heparin
Chromatography ............................................. 165
Kurt Krapfenbauer and Michael Fountoulakis
12 Calmodulin-Binding Proteome in the Brain ................... 181
Zhiqun Zhang, Firas H. Kobeissy, Andrew K. Ottens,
Juan A. Martinez, and Kevin K.W. Wang
Part III Neuroproteomic Methodology and Bioinformatics
13 Separation of the Neuroproteome by Ion Exchange
Chromatography ............................................. 193
Brian F. Fuller and Andrew K. Ottens
14 iTRAQ-Based Shotgun Neuroproteomics ........................ 201
Tong Liu, Jun Нu, and Hong Li
15 Methods in Drug Abuse Neuroproteomics: Methamphetamine
Psychoproteome ............................................. 217
Firas H. Kobeissy, Zhiqun Zhang, Shankar Sadasivan, Mark
S. Gold, and Kevin K.W. Wang
16 Shotgun Protein Identification and Quantification by
Mass Spectrometry in Neuroproteomics ....................... 229
Bingwen Lu, Tao Xuy Sung Kyu Park, Daniel B. McClatchy,
Lujian Liao, and John R. Yates, III
Part IV Biofluid Analysis and Clinical Translation
17 Identification of Glycoproteins in Human Cerebrospinal
Fluid ...................................................... 263
Hye Jin Hwang, Thomas Quinn, and Jing Zhang
18 Mass Spectrometric Analysis of Body Fluids for Biomarker
Discovery .................................................. 277
David M. Good and Joshua J. Coon
19 Traumatic Brain Injury Biomarkers: From Pipeline to
Diagnostic Assay Development ............................... 293
Monika W. Oli, Ronald L. Hayes, Gillian Robinson, and
Kevin K.W. Wang
20 Translation of Neurological Biomarkers to Clinically
Relevant Platforms ......................................... 303
Ronald L. Hayes, Gillian Robinson, Uwe Muller, and Kevin
K.W. Wang
Index ......................................................... 315
|